Publicacións (36) Publicacións de VICTOR TAPIAS MOLINA

2023

  1. Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer’s Disease and Parkinson’s Disease

    Antioxidants, Vol. 12, Núm. 6

2022

  1. Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer’s disease

    Nature Communications, Vol. 13, Núm. 1

  2. Amyloid Beta Oligomers-Induced Ca2+ Entry Pathways: Role of Neuronal Networks, NMDA Receptors and Amyloid Channel Formation

    Biomedicines, Vol. 10, Núm. 5

  3. Blueberry juice augments exercise-induced neuroprotection in a Parkinson's disease model through modulation of GDNF levels

    IBRO Neuroscience Reports, Vol. 12, pp. 217-227

  4. Environmental enrichment improves traumatic brain injury-induced behavioral phenotype and associated neurodegenerative process

    Experimental Neurology, Vol. 357

2020

  1. Isotope-reinforced polyunsaturated fatty acids improve Parkinson’s disease-like phenotype in rats overexpressing α-synuclein

    Acta Neuropathologica Communications, Vol. 8, Núm. 1

2019

  1. Phenothiazine normalizes the NADH/NAD + ratio, maintains mitochondrial integrity and protects the nigrostriatal dopamine system in a chronic rotenone model of Parkinson's disease

    Redox Biology, Vol. 24

  2. Editorial: Mitochondria and Endoplasmic Reticulum Dysfunction in Parkinson’s Disease

    Frontiers in Neuroscience

  3. Editorial: Mitochondrial Dysfunction and Neurodegeneration

    Frontiers in Neuroscience

2018

  1. Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy

    Human Molecular Genetics, Vol. 27, Núm. 16, pp. 2874-2892

  2. Mitochondrial Complex i Reversible S-Nitrosation Improves Bioenergetics and Is Protective in Parkinson's Disease

    Antioxidants and Redox Signaling, Vol. 28, Núm. 1, pp. 44-61

  3. Resveratrol and pinostilbene confer neuroprotection against aging-related deficits through an ERK1/2-dependent mechanism

    Journal of Nutritional Biochemistry, Vol. 54, pp. 77-86

2017

  1. ABCA1 Deficiency Affects Basal Cognitive Deficits and Dendritic Density in Mice

    Journal of Alzheimer's Disease, Vol. 56, Núm. 3, pp. 1075-1085

  2. Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production

    Cellular and Molecular Life Sciences, Vol. 74, Núm. 15, pp. 2851-2874

2016

  1. Impact of the sensory neurons on melanoma growth in vivo

    PLoS ONE, Vol. 11, Núm. 5

2015

  1. Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats

    Neurobiology of Aging, Vol. 36, Núm. 1, pp. 505-518

  2. Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice

    Brain, Vol. 138, Núm. 12, pp. 3699-3715

  3. ShRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model

    Journal of Clinical Investigation, Vol. 125, Núm. 7, pp. 2721-2735

2014

  1. A rapid and sensitive automated image-based approach for in vitro and in vivo characterization of cell morphology and quantification of cell number and neurite architecture

    Current Protocols in Cytometry

  2. Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease

    Neurobiology of Aging, Vol. 35, Núm. 5, pp. 1162-1176